Hytn Innovations Inc. Stock
€0.12
Your prediction
Hytn Innovations Inc. Stock
Pros and Cons of Hytn Innovations Inc. in the next few years
Pros
Cons
News
HYTN Drug Establishment Licence Expanded to Include Active Pharmaceutical Ingredients and Pharmaceutical Oils
Vancouver, British Columbia – May 7th, 2026 – HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products
HYTN Successfully Exports GMP-Manufactured Vape Cartridges
VANCOUVER, British Columbia, April 30, 2026 -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products
HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business
Vancouver, British Columbia, April 23, 2026 - HYTN Innovations Inc. (CSE: HYTN) (OTC Pink: HYTNF) (FSE: 85W0) ("HYTN" or the "Company") announces that its Board of Directors has approved the

